Correlation Between Anika Therapeutics and Vanguard ESG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Vanguard ESG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Vanguard ESG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and Vanguard ESG Corporate, you can compare the effects of market volatilities on Anika Therapeutics and Vanguard ESG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Vanguard ESG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Vanguard ESG.

Diversification Opportunities for Anika Therapeutics and Vanguard ESG

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Anika and Vanguard is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Vanguard ESG Corporate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard ESG Corporate and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Vanguard ESG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard ESG Corporate has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Vanguard ESG go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Vanguard ESG

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Vanguard ESG. In addition to that, Anika Therapeutics is 17.46 times more volatile than Vanguard ESG Corporate. It trades about -0.17 of its total potential returns per unit of risk. Vanguard ESG Corporate is currently generating about 0.07 per unit of volatility. If you would invest  6,283  in Vanguard ESG Corporate on August 31, 2024 and sell it today you would earn a total of  40.00  from holding Vanguard ESG Corporate or generate 0.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Anika Therapeutics  vs.  Vanguard ESG Corporate

 Performance 
       Timeline  
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vanguard ESG Corporate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanguard ESG Corporate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Vanguard ESG is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Anika Therapeutics and Vanguard ESG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anika Therapeutics and Vanguard ESG

The main advantage of trading using opposite Anika Therapeutics and Vanguard ESG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Vanguard ESG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard ESG will offset losses from the drop in Vanguard ESG's long position.
The idea behind Anika Therapeutics and Vanguard ESG Corporate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges